Mesoporous silica nanoparticles (MSNs) bearing poly( l -histidine)-grafted nanogates were prepared by surface-initiated ROP. The obtained polypeptide-functionalized MSNs were used as smart pH-responsive nanocarriers for controlled drug release applications.
No takes yet. Share an insight, caveat, or question.
Bilalis et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: